• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.27% Nasdaq Down 0.19%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    19.52 Down 0.06(0.31%) Aug 4, 4:00PM EDT
    Add to Portfolio
    Prev Close:19.58
    Open:19.51
    Bid:N/A
    Ask:21.75 x 500
    1y Target Est:24.57
    Beta:0.95
    Next Earnings Date: 5-Aug-15AEGR Earnings announcement
    Day's Range:19.11 - 19.96
    52wk Range:16.68 - 36.19
    Volume:614,668
    Avg Vol (3m):596,612
    Market Cap:557.73M
    P/E (ttm):N/A
    EPS (ttm):-1.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 0.31%557.73M
    AZNUp 1.18%43.41B
    MRKDown 0.59%165.84B
    PFEDown 0.11%220.63B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.93
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.58
    Quarterly EPS Est (Jun-15) :-0.28
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):-2.42

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback